Literature DB >> 8148463

Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases.

D C Dale1.   

Abstract

The colony-stimulating factors (CSFs) principally involved in the production of neutrophils and monocytes are granulocyte CSF, granulocyte-macrophage CSF, macrophage CSF, and interleukin 3 (sometimes called multi-CSF). The natural response to inflammation and infection in the immunocompetent host probably involves all of these CSFs. CSFs can be used as pharmacological agents to accelerate the production of neutrophils and monocytes/macrophages and to enhance mechanisms of host defense. Rapidly accumulating evidence appears to justify the use of CSFs for the prevention of fever and infections in several clinical settings, such as chemotherapy-associated neutropenia, bone marrow transplantation, and severe chronic neutropenia. Trials of CSF treatment of infections in settings not including neutropenia are under way.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148463     DOI: 10.1093/clinids/18.supplement_2.s180

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.

Authors:  M Ray; K Mukhopadhyay; A Narang
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

2.  Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.

Authors:  W N Hustinx; C P Van Kessel; E Heezius; S Burgers; J W Lammers; I M Hoepelman
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.